Oncotarget

Oncotarget Videos

Harvard Medical School's Dr. Carmelo Nucera talks about his Publication in the Open-access Bio-medical Journal Oncotarget

Correspondence to - Carmelo Nucera, email: cnucera@bidmc.harvard.edu

Keywords: papillary thyroid cancer preclinical model, BRAFV600E, chromosome 5, combined therapy with vemurafenib and palbociclib, drug resistance



Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC